Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Treatment of a patient with epidermodysplasia verruciformis carrying a novel EVER2 mutation with imiquimod.

Journal of the American Academy of Dermatology - 1 May 2007

Berthelot Cindy, Dickerson Mary C, Rady Peter, He Qin, Niroomand Farhad, Tyring Stephen K, Pandya Amit G

Abstract excerpt

Epidermodysplasia verruciformis (EV) is a rare disorder characterized by widespread human papillomavirus infection and malignant transformation. EV may be caused by mutations of the genes EVER1 or EVER2, which are located on the EV1 locus, 17q25. We describe a patient with EV and a novel homozygous gene mutation of EVER2 gene who was treated successfully with topical imiquimod.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Administration, Topical
Share to Aminoquinolines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antineoplastic Agents

Share to Carcinoma, Basal Cell

Share to Carcinoma, Squamous Cell

Share to Membrane Proteins

Share to Mutation

Share to Skin Neoplasms

Source

Identifiers

PMID: 17368633
DOI: 10.1016/j.jaad.2007.01.036

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Treatment of a patient with epidermodysplasia verruciformis carrying a novel EVER2 mutation with imiquimod.PMID 17368633Read ↗

Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis.Semantic proximity Read ↗

Autosomal dominant epidermodysplasia verruciformis lacking a known EVER1 or EVER2 mutation.Semantic proximity Read ↗

Novel homozygous frameshift mutation of EVER1 gene in an epidermodysplasia verruciformis patient.Semantic proximity Read ↗

Dye laser photodynamic therapy for Bowen's disease in a patient with epidermodysplasia verruciformis.Semantic proximity Read ↗

A distinct variant of Epidermodysplasia verruciformis in a Turkish family lacking EVER1 and EVER2 mutations.Semantic proximity Read ↗

Re-evaluation of epidermodysplasia verruciformis: Reconciling more than 90 years of debate.Semantic proximity Read ↗

A novel approach to the classification of epidermodysplasia verruciformisSemantic proximity Read ↗

A Novel Large Deletion in the EVER1 Gene in a Family With Epidermodysplasia Verruciformis From India.Semantic proximity Read ↗

Novel mutations of EVER1/TMC6 gene in a Japanese patient with epidermodysplasia verruciformisSemantic proximity Read ↗

Epidermodysplasia verruciformis in a HIV-positive patient homozygous for the c917A-->T polymorphism in the TMC8/EVER2 gene.Semantic proximity Read ↗

Epidermodysplasia verruciformis.Semantic proximity Read ↗

CD8+ T-cell lymphocytopenia and lack of EVER mutations in a patient with clinically and virologically typical epidermodysplasia verruciformis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.